Beckman Coulter Life Sciences acquires Dublin biotech start-up
Beckman Coulter Life Sciences announces it has acquired ValitaCell Ltd. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to market. Compared to other industry IgG quantification assays, the ValitaTiter product outperforms in terms of speed and ease of use, and offers numerous advantages over other long and tedious techniques, like ELISA and HPLC.
ValitaCell joins Beckman Coulter Life Sciences
Beckman Coulter Life Sciences
“ValitaCell has a proven record for delivering innovative products and we are excited to build upon our successful partnership with Beckman Coulter Life Sciences,” said Dr. Jerry Clifford, Co-Founder and CEO of ValitaCell. “We never take for granted what our advancements can do for patients while also reducing manual workflow burdens on laboratory staff. Together with Beckman Coulter Life Sciences, we will advance our shared ambition to accelerate and enable the sustainable manufacture of innovative biological medicines to bring them to market faster.”
ValitaCell technologies are patented in key international markets and the company has been honored with several awards, including the Irish Pharmaceutical Awards’ Pharma Start-up of the Year in 2017 and InterTrade Ireland’s Seedcorn awards. It also was recognized as one of the most successful Irish companies in Horizon 2020.
“Throughout our trusted partnership with ValitaCell, we have long admired their innovative offerings and industry expertise,” said Jason Lanie, Vice President and General Manager of the Biotechnology Business Unit at Beckman Coulter Life Sciences. “Their leading portfolio of products, including ValitaTiter, Quantum, CellAi, and ChemStress Clone Robustness complement Beckman Coulter Life Sciences’ existing and future product portfolio, and are designed with the same goal of providing faster cellular analysis while decreasing the risk of errors. We are excited to welcome their team and look forward to growing the Ireland Innovation and Development Centers for Biologics to help meet evolving customer needs.”
ValitaCell locations in Dublin and Galway, Ireland will remain operational and are anticipated to grow in response to business needs.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
Last viewed contents
Researchers find metal gets stronger with three or more line dislocations
General Lab and Labco to create a leading European medical diagnostics Group
A new iconic drug information system inspired by road signs
The Science Advisory Board report shows increase in usage of key protein research techniques
Science on the back burner: European laboratories struggle with massive restrictions - Great sustainability ambitions and willingness to innovate despite the need to save money
Genzyme Launches Key Test To Monitor Gleevec Resistance - Two Additional Personalized Medicine Tests Also Available
Michael Siekiera joins management board at Hahnemühle
Measurement of lower aldehydes especially acrolein with the 2-HMP method - GC method
BIOTECON Diagnostics signs license agreement with Applera Corporation
'Tickling' an atom to investigate the behavior of materials
Inner workings of photosynthesis revealed by powerful new laser technique